ATE136121T1 - Downsyndrom-screening-methode - Google Patents

Downsyndrom-screening-methode

Info

Publication number
ATE136121T1
ATE136121T1 AT90903086T AT90903086T ATE136121T1 AT E136121 T1 ATE136121 T1 AT E136121T1 AT 90903086 T AT90903086 T AT 90903086T AT 90903086 T AT90903086 T AT 90903086T AT E136121 T1 ATE136121 T1 AT E136121T1
Authority
AT
Austria
Prior art keywords
reference data
pregnant woman
chorionic gonadotropin
human chorionic
beta subunit
Prior art date
Application number
AT90903086T
Other languages
English (en)
Inventor
James N Macri
Original Assignee
James N Macri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27540826&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE136121(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by James N Macri filed Critical James N Macri
Application granted granted Critical
Publication of ATE136121T1 publication Critical patent/ATE136121T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Immunology (AREA)
  • Data Mining & Analysis (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Tests Of Electronic Circuits (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Image Processing (AREA)
  • Paper (AREA)
AT90903086T 1989-01-17 1990-01-16 Downsyndrom-screening-methode ATE136121T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29748189A 1989-01-17 1989-01-17
US31180889A 1989-02-17 1989-02-17
US34937389A 1989-05-08 1989-05-08
US36060389A 1989-06-02 1989-06-02
US42077589A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
ATE136121T1 true ATE136121T1 (de) 1996-04-15

Family

ID=27540826

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90903086T ATE136121T1 (de) 1989-01-17 1990-01-16 Downsyndrom-screening-methode
AT95104733T ATE252240T1 (de) 1989-01-17 1990-01-16 Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95104733T ATE252240T1 (de) 1989-01-17 1990-01-16 Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes

Country Status (9)

Country Link
US (1) US5324668A (de)
EP (2) EP0666477B1 (de)
JP (1) JP2644373B2 (de)
AT (2) ATE136121T1 (de)
AU (1) AU629908B2 (de)
DE (2) DE69026153T3 (de)
DK (2) DK0409956T4 (de)
ES (2) ES2210266T3 (de)
WO (1) WO1990008325A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666477B1 (de) * 1989-01-17 2003-10-15 JN Macri Technologies LLC, Inc. Einrichtung zum Nachweis vom Down syndrom durch nichtinvasive Siebtestung des mütterlichen Blutes
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) * 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9315230D0 (en) * 1993-07-22 1993-09-08 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
JP3703858B2 (ja) * 1993-09-30 2005-10-05 シスメックス株式会社 帰属度判別装置
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
US5606164A (en) * 1996-01-16 1997-02-25 Boehringer Mannheim Corporation Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
DK1076824T3 (da) 1998-04-29 2006-09-18 Nicholas John Wald Prænatal screening for Downs syndrom
US7041466B2 (en) * 2002-08-05 2006-05-09 Auburn University Mouse disease model for evaluation of prophylactic and therapeutic treatments of Chlamydia
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
WO2005035725A2 (en) * 2003-10-08 2005-04-21 The Trustees Of Boston University Methods for prenatal diagnosis of chromosomal abnormalities
AU2006226891A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
EP2076172A4 (de) * 2006-10-27 2012-03-21 Aretais Inc Verwendung kohärenter raman-verfahren für medizinische diagnostische und therapeutische zwecke sowie kalibrierverfahren dafür
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
CN103076458A (zh) * 2012-12-16 2013-05-01 北京利德曼生化股份有限公司 游离人绒毛膜促性腺激素β亚单位磁微粒化学发光法定量测定试剂盒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4123224A (en) * 1975-12-17 1978-10-31 American Home Products Corporation Diagnostic test device
JPS54126723A (en) * 1978-03-23 1979-10-02 Teikoku Hormone Mfg Co Ltd Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
DE3112767A1 (de) * 1981-03-31 1982-11-11 Werner Dr.med. 1000 Berlin Steinschulte Heimcomputer zur natuerlichen familienplanung (nfp) und zur gynaekologisch-endokrinologischen diagnostik
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
GR850899B (de) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
ATE91182T1 (de) * 1987-07-09 1993-07-15 3I Res Expl Ltd Praenatales screening fuer downs-syndrom.
US5037305A (en) * 1988-11-16 1991-08-06 Vivigen, Inc. Graphic method for reporting risk to a patient
EP0666477B1 (de) * 1989-01-17 2003-10-15 JN Macri Technologies LLC, Inc. Einrichtung zum Nachweis vom Down syndrom durch nichtinvasive Siebtestung des mütterlichen Blutes

Also Published As

Publication number Publication date
AU629908B2 (en) 1992-10-15
DE69026153T3 (de) 2005-05-12
US5324668A (en) 1994-06-28
ATE252240T1 (de) 2003-11-15
ES2084689T3 (es) 1996-05-16
EP0409956B2 (de) 2004-07-21
EP0666477B1 (de) 2003-10-15
DK0409956T4 (da) 2004-09-06
ES2084689T5 (es) 2005-03-01
DE69034111D1 (de) 2003-11-20
EP0409956B1 (de) 1996-03-27
AU5093690A (en) 1990-08-13
EP0409956A1 (de) 1991-01-30
JPH03505128A (ja) 1991-11-07
ES2210266T3 (es) 2004-07-01
DE69026153T2 (de) 1996-09-19
DE69026153D1 (en) 1996-05-02
DK0409956T3 (da) 1996-04-29
EP0666477A1 (de) 1995-08-09
DE69034111T2 (de) 2004-07-29
JP2644373B2 (ja) 1997-08-25
DK0666477T3 (da) 2004-02-23
WO1990008325A1 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
ATE136121T1 (de) Downsyndrom-screening-methode
Pierson et al. Ultrasonic evaluation of the corpus luteum of the mare
PT1076824E (pt) Avaliacao pre-natal do sindroma de down
DE3776190D1 (de) Dreidimensionaler digitalumformer zur skelettanalyse.
DE69030832D1 (de) Automatische Analysevorrichtung und Verfahren für klinische Untersuchung
ATA27189A (de) Vorrichtung zur bestimmung zumindest einer medizinischen messgroesse
ATE412896T1 (de) Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin
Honda et al. An MRI study on the relationship between oral cavity shape and larynx position
McCloskey et al. Chemical composition of the rabbit aorta during development
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
ATE38521T1 (de) Neues protein (pp13), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
PT80743A (fr) Sonde et procede pour le diagnostic du sexe d'un embryon humain
DE3882140D1 (en) Praenatales screening fuer downs-syndrom.
DODO Appearance of bony bridging of the hypoglossal canal during the fetal period
IL49130A0 (en) Method and instrument for rapid diagnosis of fetus maturity
CAMPBELL et al. Erythropoietin levels in amniotic fluid and extraembryonic coelomic fluid in the first trimester of pregnancy
Stoz et al. The development of the placental villus during normal pregnancy: morphometric data base
GB9306354D0 (en) Antenatal screening for chromosomal abnormalities
ATE117090T1 (de) Verfahren zur diagnose von tumoren.
DE69011917D1 (de) Vorrichtung für die automatische Gültigkeitsanalyse von medizinischen Prüfdaten.
Kanisius et al. Is the complexity of the human sagittal suture related to the size of the temporal muscle?
Kellokumpu-Lehtinen Age determination of early human embryos and fetuses
ATE133549T1 (de) Vorrichtung zur messung der gebärmuttersenkung
Merilan Bovine pregnancy detection by nuclear magnetic resonance spectra of cervical mucus
Madrid et al. Circumflex occlusion and posterior myocardial infarction: Diagnostic criteria and automated ECG analysis programs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0409956

Country of ref document: EP

EELA Cancelled due to lapse of time